Comparison of questionnaires used for screening and symptom identification in hypogonadal men - Abstract

Late-onset hypogonadism (LOH) is typically defined as the cluster of symptoms appearing in aging men and accompanied by a decrease in serum testosterone levels.

The identification of a simple screening tool with a high level of sensitivity and specificity to predict LOH has remained a challenge. To identify men with LOH, a variety of self-administered questionnaires have been developed including The Saint Louis University Androgen Deficiency in the Aging Male (ADAM) Questionnaire, The Quantitative ADAM (qADAM) Questionnaire, The Aging Male Symptoms (AMS) rating scale, The Massachusetts Male Aging Study (MMAS) questionnaire and The New England Research Institutes (NERI) hypogonadism questionnaire. The applicability of these questionnaires in the clinical setting is debated because some of the symptoms associated with LOH could be attributed to the natural process of aging and comorbidities. The goal of this review is to compare the utility and the validity of the different LOH questionnaires.

Written by:
Bernie AM1, Scovell JM, Ramasamy R.   Are you the author?
Department of Urology, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, USA.

Reference: Aging Male. 2014 Sep 23:1-4.
doi: 10.3109/13685538.2014.963041


PubMed Abstract
PMID: 25247629

UroToday.com Androgen Deficiency Section